Garuda - Garba Rujukan Digital

p-Index From 2021 - 2026

11.814

P-Index

This Author published in this journals

All Journal IAES International Journal of Artificial Intelligence (IJ-AI) International Journal of Public Health Science (IJPHS) Jurnal Ilmiah Farmasi Journal of the Medical Sciences (Berkala Ilmu Kedokteran) Pharmaciana: Jurnal Kefarmasian Media Farmasi : Jurnal Ilmu Farmasi (Journal Of Pharmaceutical Science) Jurnal Farmasi Klinik Indonesia Indonesian Journal of Biotechnology Global Medical and Health Communication Jurnal Ilmu Farmasi dan Farmasi Klinik (Journal of Pharmaceutical Science and Clinical Pharmacy) Mutiara Medika: Jurnal Kedokteran dan Kesehatan Pharmacon INDONESIAN JOURNAL OF PHARMACY Pharmascience JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA Public Health of Indonesia Jurnal Farmasi Sains dan Komunitas THE JOURNAL OF MUHAMMADIYAH MEDICAL LABORATORY TECHNOLOGIST Jurnal Surya Medika Jurnal Penelitian Pendidikan IPA (JPPIPA) JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice) Jurnal Ilmiah Ibnu Sina (JIIS): Ilmu Farmasi dan Kesehatan Majalah Farmaseutik JPSCR : Journal of Pharmaceutical Science and Clinical Research PHARMACY: Jurnal Farmasi Indonesia (Pharmaceutical Journal of Indonesia) JFIOnline Jurnal Ilmu Kefarmasian Indonesia JCPS (Journal of Current Pharmaceutical Sciences) Medica Hospitalia Jurnal Farmagazine Jurnal Health Sains Journal of Holistics and Health Sciences (JHHS) Jurnal Insan Farmasi Indonesia Jurnal Ilmiah Ibnu Sina (JIIS): Ilmu Farmasi dan Kesehatan Medical Sains : Jurnal Ilmiah Kefarmasian Jurnal Sintesis: Penelitian Sains, Terapan dan Analisisnya JKKI : Jurnal Kedokteran dan Kesehatan Indonesia Jurnal Farmasi Klinik dan Sains Borobudur Pharmacy Review Jurnal Permata Indonesia Sciences of Pharmacy Journal of Global Pharma Technology Borneo Journal of Pharmacy Kartika : Jurnal Ilmiah Farmasi Medical Sains : Jurnal Ilmiah Kefarmasian Pharmacon: Jurnal Farmasi Indonesia Jurnal Sains dan Kesehatan Jurnal Farmasi Galenika Indonesian Journal of Pharmacology and Therapy

Dyah Aryani Perwitasari

Fakultas Farmasi, Universitas Ahmad Dahlan

Author-ID : 342319

Agriculture, Biological Sciences & Forestry Biochemistry, Genetics & Molecular Biology Chemical Engineering, Chemistry & Bioengineering Chemistry Computer Science & IT Dentistry Education Engineering Environmental Science Health Professions Immunology & microbiology Materials Science & Nanotechnology Mathematics Medicine & Pharmacology Neuroscience Nursing Physics Public Health Social Sciences Veterinary Other

Published : 174 Documents Claim Missing Document

Claim Missing Document

Articles

12 13 14 15 16

Hipertensi pada Pasien Kanker Kolorektal Metastatik dengan Terapi Bevacizumab di RSUP Dr. Kariadi Septiantoro, Bayu Prio; Perwitasari, Dyah Aryani; Faridah, Imaniar Noor; Pradipta, Indra
Medica Hospitalia : Journal of Clinical Medicine Vol. 7 No. 2 (2020): Med Hosp
Publisher : RSUP Dr. Kariadi

Latar belakang: Kanker kolorektal saat ini sudah menjadi penyebab utama ketiga kematian akibat kanker di dunia, penyakit ini membutuhkan terapi yang progresif dimana salah satu terapinya adalah bevacizumab. Namun diketahui bevacizumab dapat menimbulkan hipertensi pada sebagian pasien. Penelitian ini bertujuan untuk untuk mengetahui onset terjadinya hipertensi akibat bevacizumab dengan rejimen kemoterapi apa yang digunakan. Metode: Penelitian ini merupakan sebuah tinjauan deskriptif restrospektif yang dilakukan di RSUP Dr. Kariadi, Semarang. Kriteria inklusi terdiri dari pasien kanker kolorektal metastatik yang berusia ? 18 tahun dengan hipertensi tingkat ?2 berdasarkan NCI CTCAE version 5.0 setelah diberikan terapi bevacizumab 5 mg/kg berat badan di RSUP Dr. Kariadi. Pengambilan data dalam 1 tahun (bulan April 2018 hingga April 2019) melalui peninjauan dari rekam medis, laporan penggunaan obat bevacizumab dan laporan penggunaan obat kardiovaskuler instalasi farmasi. Kriteria ekslusi dalam penelitian ini yaitu hipertensi tingkat ?2 berdasarkan NCI CTCAE version 5.0 yang muncul setelah ?4 kali waktu paruh bevacizumab (t 1/2 = 20 hari) dari kemoterapi yang terakhir. Hasil: Total 95 pasien sesuai kriteria, sebanyak 24 pasien (25,26%) teridentifikasi mengalami hipertensi tingkat ? 2 berdasarkan NCI CTCAE version 5.0. Dengan 20 pasien (83,33%) pasien mendapatkan kemoterapi rejimen FOLFOX4, sedangkan sisanya (16,66%) dengan rejimen de Gramont. Hipertensi ini muncul sebagian besar pada siklus III, diikuti siklus ke II, ke I dan ke VI. Tidak satupun pasien dengan kombinasi FOLFIRI yang terdeteksi mengalami hipertensi ini. Kesimpulan: Penelitian ini menunjukkan onset munculnya hipertensi tingkat ?2 NCI CTCAE version 5.0 paling banyak adalah pada siklus awal terapi yaitu I-III dan dengan rejimen kombinasi FOLFOX4 + bevacizumab. Kata Kunci: Kanker kolorektal, bevacizumab, hipertensi Background: Colorectal cancer nowadays is the third leading cause of cancer deaths in the world, this disease requires progressive therapy where one of the treatments is bevacizumab. But it is known that bevacizumab can cause hypertension in some patients. This study aims to determine the onset of the hypertension with chemotherapy regimen used. Method: This research is a retrospective descriptive review conducted at Dr. Kariadi General Hospital, Semarang. Inclusion criteria consisted of metastatic colorectal cancer patients aged ?18 years old with hypertension level ?2 based on NCI CTCAE version 5.0 after being given bevacizumab therapy dose 5 mg/kg body weight. Retrieval of data in 1 year (April 2018 to April 2019) through a review of medical records, reports on the use of bevacizumab drugs and reports on the use of cardiovascular drugs in Department of Pharmacy. The exclusion criteria in this study were hypertension level on NCI CTCAE version 5.0 which appeared after 4 times the half-life of bevacizumab (t 1/2 = 20 days) from the last chemotherapy. Result: Total 95 patients according to the criteria, 24 patients (25.26%) were identified as having hypertension level ? 2 based on NCI CTCAE version 5.0. With 20 patients (83.33%) patients received FOLFOX4 regimen, while the rest (16.66%) with de Gramont regimen. This hypertension occurs mostly in cycle III, followed by cycle II, to I and to VI. None of the patients with a combination of FOLFIRI. Conclusion: This research shows that the onset of hypertension level ?2 NCI CTCAE version 5.0 mostly in the initial cycle of therapy (I-III) with the FOLFOX4 + bevacizumab combination regimen. Keywords: Colorectal cancer, bevacizumab, hypertension

Gangguan Neuropsikiatri Paska Kemoterapi Ifosfamid Septiantoro, Bayu Prio; Perwitasari, Dyah Aryani; Farida, Imaniar Noor
Medica Hospitalia : Journal of Clinical Medicine Vol. 8 No. 1 (2021): Med Hosp
Publisher : RSUP Dr. Kariadi

Latar belakang: Reaksi obat yang merugikan (adverse drug reaction) sering muncul salah satunya pada obat-obat sitostatika. Ifosfamid adalah obat sitostatika golongan pengalkil yang ketika dimetabolisme akan membentuk senyawa aktif nitrogen mustard sitotoksik. Selain itu ia juga membentuk senyawa lain yaitu akrolein dan kloroasetaldehid. Akrolein yang bersifat urotoksik ini dengan mudah akan diikat oleh mesna, sedangkan kloroasetaldehid bersifat neurotoksik yang hingga sampai saat ini masih menjadi masalah karena keterbatasan panduan untuk anti dotumnya. Kasus: Kami mendeskripsikan 3 pasien dengan diagnosis berbeda yang mengalami gangguan neuropsikiatri paska kemoterapi ifosfamid yaitu kanker saluran empedu dengan mengantuk berat, kanker ovarium residif dengan halusinasi, dan tumor ganas pelvis dengan penurunan kesadaran disertai kejang. Pembahasan: Gangguan neuropsikiatri dapat disebabkan oleh neurotoksisitas dari hasil metabolisme dari ifosfamid yaitu kloroasetaldehid yang secara langsung maupun tidak langsung merusak neuron (neurotoksik). Manifestasi klinisnya dapat bertingkat mulai dari kebingungan dan mengantuk hingga kejang, koma dan kematian. Onset munculnya gejala terutama hitungan jam hingga 2 hari setelah kemoterapi selesai. Terdapat faktor resiko munculnya neurotoksisitas yang teridentifikasi pada laporan kasus ini yaitu gangguan fungsi ginjal dan hipoalbumin. Beberapa penelitian mengatakan bahwa toksistas ini berifat reversible, demikian juga dengan pasien kasus pertama yang membaik setelah 24 jam, dan kasus kedua yang membaik setelah 5 hari, namun pemberian terapi spesifik tetap direkomendasikan pada NCI stadium III atau IV. Kesimpulan: Gangguan neuropsikiatri paska kemoterapi ifosfamid dapat disebabkan oleh neurotoksisitas pada SSP akibat kloroasetaldehid dengan faktor resiko yaitu gangguan fungsi ginjal dan hipoalbumin. Diperlukan penelitian lebih lanjut untuk memastikan bahwa gejala neuropsikiatri yang muncul adalah murni karena ifosfamid, misalnya dengan melakukan pengukuran kadar obat di dalam darah.

Genetic polymorphism and the risk of diabetic foot: a bibliometric analysis from 2011-2021 Maliza, Rita; Irham, Lalu Muhammad; Pradika, Jaka; Pratama, Kharisma; Dania, Haafizah; Arya, Bramadi; Perwitasari, Dyah Aryani
International Journal of Public Health Science (IJPHS) Vol 12, No 4: December 2023
Publisher : Intelektual Pustaka Media Utama

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.11591/ijphs.v12i4.23028

Diabetic foot ulcer (DFU) has been associated with genetic and environmental factors, which could potentially have a role in DFU development. Single nucleotide polymorphisms (SNPs) in genes linked to DFU, including inflammation. Bibliometric studies on the SNP on genes affecting DFU still have not been evaluated. This study aims to depict bibliographically and understand the topic trend of genetic polymorphism and the risk of DFU publications. A bibliometric methodology was applied in this study. The data were extracted through the Scopus database from 2011 to 2021. VOS viewer was used to classify and summarize Scopus articles. The 35 articles were evaluated. India topped the list of countries with the most publications, and Tehran University of Medical Sciences was the primary institution. Singh K and his team were the first contributing authors with 44 citations. Keywords analysis indicated that the research hotspots were DFU, type 2 diabetes mellitus (T2DM), diabetic foot ulcers, polymorphisms, hypoxia, vascular endothelial growth factor (VEGF), diabetic foot, diabetes mellitus, and oxidative stress. This study summarizes the current state, trends in genetic polymorphism and risk with DFU research. It may provide researchers with insight into the genetic polymorphism and risk associated with DFU research, as well as useful information for identifying possible collaborators and partner institutions.

Effectiveness of Machine Learning for COVID-19 Patient Mortality Prediction Using WEKA Khuluq, Husnul; Yusuf, Prasandhya Astagiri; Perwitasari, Dyah Aryani
Global Medical & Health Communication (GMHC) Vol 11, No 3 (2023)
Publisher : Universitas Islam Bandung

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.29313/gmhc.v11i3.12119

Timely detection of patients with a high mortality risk in coronavirus disease 2019 (COVID-19) can substantially improve triage, bed allocation, time reduction, and potential outcomes. A potential solution is using machine learning (ML) algorithms to predict mortality in COVID-19 hospitalized patients. The study's objective was to create and verify individual risk assessments for mortality using anonymous demographic, clinical, and laboratory findings at admission, as well as to assess the possibility of death using machine learning. We used a standardized format and electronic medical records. Data from 2,313 patients were collected from two Muhammadiyah hospitals from January 2020 to July 2022. Utilizing each patient's clinical manifestation state at admission and laboratory parameters, 24 demographic, clinical, and laboratory results were studied. The algorithms analyzed were AdaBoost, logistic regression, random forest, support vector machine, naïve Bayes, and decision tree, which were applied through WEKA version 3.8.6. Random forest performed better than the other machine learning techniques, with precision, sensitivity, receiver operating characteristic (ROC), and accuracy of 78.6%, 78.7%, 85%, and 78.65%, respectively. The three top predictors were septic shock (OR=21.518, 95% CI=4.933–93.853), respiratory failure (OR=15.503, 95% CI=8.507–28.254), and D-dimer (OR=3.288, 95% CI=2.510–4.306). Machine learning–based predictive models, especially the random forest algorithm, may make it easier to identify patients at high risk of death and guide physicians' appropriate interventions.

REAL WORLD DATA : ANTIVIRUS SELECTION IN COVID-19 PATIENTS AT PKU MUHAMMADIYAH GAMPING HOSPITAL Damayanti, Hazena Misgi; Perwitasari, Dyah Aryani; Risdiana, Irma; Kuluq, Muhammad Husnul
Medical Sains : Jurnal Ilmiah Kefarmasian Vol 9 No 3 (2024)
Publisher : Sekolah Tinggi Farmasi Muhammadiyah Cirebon

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37874/ms.v9i3.1125

COVID-19 is a disease that requires antivirals, such as favipiravir and remdesivir, which have been recommended in Indonesia. Choosing the right antiviral agent can affect the length and total cost of hospitalization. The impact of COVID-19 can cause a decline in health and the economy, if not treated effectively. This study aimed to determine the average length of hospitalization and total cost of hospitalization for COVID-19 patients based on the selection of favipiravir and remdesivir antivirals at the PKU Muhammadiyah Gamping Hospital from August 2022-August to 2023 based on real world data. The research method was Observational research with a descriptive research design and retrospective data collection was used. During this period, 306 patients were diagnosed with COVID-19. A total of 171 patients met the inclusion criteria, including 130 patients using favipiravir antivirus and 41 patients using remdesivir antivirus. The results of this study are the average length of hospitalization of the patient group with antiviral favipiravir was 4.1 days and the patient group with antiviral remdesivir was 5 days and the average total cost of hospitalization of the patient group with antiviral favipiravir was IDR 12,377,415 and the average total cost of the patient group with antiviral remdesivir was IDR 14,428,132. The conclusion of this study is that the use of favipiravir antiviral therapy is more effective when viewed from the perspective of length of hospitalization and total cost of hospitalization; therefore, these results can be applied under the same conditions in the treatment of COVID-19.

Hubungan Terapi Kombinasi Mood Stabilizer dan Antipsikotik dengan Kemampuan Fungsional Pasien Gangguan Afektif Bipolar di Rumah Sakit Jiwa Grhasia Yogyakarta : Relationship between Mood Stabilizer and Antipsychotic Combination Therapy with Functional Ability of Bipolar Affective Disorder Patients at Grhasia Mental Hospital Yogyakarta Nadia Utami Noor; Dyah Aryani Perwitasari; Sawitri Sawitri
Jurnal Sains dan Kesehatan Vol. 3 No. 5 (2021): J. Sains Kes.
Publisher : Fakultas Farmasi, Universitas Mulawarman, Samarinda, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.25026/jsk.v3i5.536

Bipolar disorder is a mental illness that can affect the functional abilities of the patients. It is persistent even in a euthymic condition. There have been number of studies on the effectiveness of mood stabilizer and antipsychotic therapy in bipolar disorder, but there is still few studies related to the effect of the combination therapy of mood stabilizer and antipsychotics on bipolar patient’s functional ability. The objectives of this study is to determine the associatioin of valproate and lithium combined with antipsychotics on functional ability of bipolar disorder patients at Grhasia Mental Hospital Yogyakarta. The study design was cohort retrospective. The data was collected from medical record. The subjects were patients who were hospitalized and undergone therapy combination mood stabilizer and antipsychotics in January-December 2018. Total of 46 patients, 38 received valproate + antipsychotic and 8 patients received lithium + antipsychotic. There was no significant association between the combination therapy group on the patient’s functional abilities [ Odds Ratio (OR) = 1,71; 95% Confidence Interval (CI): 0,37-7,95 ; p = 0,963].

Quality of Life and Costs of Illness of Dengue Patients at Pku Muhammadiyah Yogyakarta and Bantul Boisi, Cici Feronika; Purwanto, Barkah Djaka; Supadmi, Woro; Faridah, Imaniar Noor; Perwitasari, Dyah Aryani
Jurnal Ilmiah Farmasi Vol. 20 No. 2 (2024): Jurnal Ilmiah Farmasi
Publisher : Universitas Islam Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20885/jif.vol20.iss2.art5

Background: The manifestation of dengue is a decrease in hematocrit and platelet levels, leading to a decrease in the patient’s quality of life and having an impact on the patient’s medical costs.Objective: This study objective was to ascertain the quality of life and medical costs associated with dengue patients.Method: This study employed a cross-sectional design at PKU Muhammadiyah Hospitals in Bantul and Yogyakarta from January to August in 2023. Pediatric patients’ quality of life was assessed using the EQ-5D-Y questionnaire, while adult patients’ using the EQ-5D-5L questionnaire. Data on patients’ medical costs was obtained from the hospital's financial database. The data were then analyzed descriptively and presented as a percentage of quality of life and average medical costs.Results: The results showed that pediatric DF patients in both hospitals reported anxiety and depression, with percentages of 100% (Yogyakarta) and 75% (Bantul), respectively. Meanwhile, most adult DF patients experienced problems in carrying out routines, 71.4% (Yogyakarta) and 50% (Bantul), respectively. Adult DHF patients in both hospitals reported pain and discomfort of 66.7% (Yogyakarta) and 100% (Bantul), respectively. The highest average medical costs paid by DF and DHF patients at PKU Jogja Hospital were IDR 4,919,450 and IDR 6,981,500. DF and DHF patients at PKU Hospital with BPJS insurance, with the highest average medical costs of IDR 2,726,245.5 (for DF patients) and IDR 4,797,700 (for DHF patients) to cover for laboratory costs.Conclusion: Dengue fever infections are impacting the patient's quality of life and medical costs.

Evaluation of adherence, distress and quality of life for type 2 diabetes melitus patients In Puskesmas Wedarijaksa I and Puskesmas Trangkil Kabupaten Pati Perwitasari, Dyah Aryani; Urbayatun, Siti; Wilisa, Oni Yulianta
Pharmaciana Vol. 8 No. 2 (2018): Pharmaciana
Publisher : Universitas Ahmad Dahlan

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.12928/pharmaciana.v8i2.10573

Diabetes mellitus is chronic disease that needs the complex and a long term medical treatment. Patient adherence and level of distress can affect patient quality of life. The purposes of this study is to examine patients adherence, distress, and quality of life patients type 2 diabetes mellitus in Kabupaten Pati. This study used cross sectional design and data patients collection techniques were conducted prospective data. The subjects of research were patients with Type 2 diabetes amounted to 126 people. Instruments used in this research is Medication Adherence Respon Scale (MARS) questionnaire to measure patients adherence, Diabetes Distress Scale (DDS) to measure distress, and EQ-5D-5L questionnaire to measure quality of life. Data analysis statistic used Mann Whiney test, and linier regression. This study was dominated by female patients 78.6%. The mean age of DMT2 patients was 54.49 Â± 6.19 years. The average value of adherence (MARS) was 21.33 Â± 2.90 including in moderate adherence. The mean total of DDS score was 1,56Â±0,42 including not distress level and the highest is the emotional burden domain. The mean value of EQ5D5L index was 0.729 Â± 0.161. The results showed a significant association (p <0.05) between patient characteristics age and duration of sick with adherence. There were significant association (p <0.05) between age to physician distress, gender with emotional, marital status with emotional and interpersonal distress, duration of sick to physician distress and management therapy distress. Marital status and income had significant relationship to quality of life. Emotional burden domain had significant relationship to quality of life. Multivariate analysis showed that the relationship of adherence and distress by the emotional burden to quality of life. This study concluded the significant relationship between adherence, distress and quality of life.

Mortality prediction of COVID-19 patients using supervised machine learning Khuluq, Husnul; Astagiri Yusuf, Prasandhya; Aryani Perwitasari, Dyah; Nguyen, Thang
IAES International Journal of Artificial Intelligence (IJ-AI) Vol 13, No 4: December 2024
Publisher : Institute of Advanced Engineering and Science

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.11591/ijai.v13.i4.pp4472-4479

Hospitalized patients with COVID-19 are at higher risk of mortality. Machine learning (ML) algorithms have been proposed as a possible strategy for predicting mortality rates among patients hospitalized with COVID-19. This study analyzed various ML algorithms and identified the best model to predict COVID-19 mortality based on demographic, clinical, and laboratory data collected at registration. Data from 4,314 eligible patients (3,384 survivors and 930 who died) was collected from the register of three hospitals in Yogyakarta province, Indonesia, based on the confirmed predictors. Next, ML algorithms were utilized to predict mortality. Finally, the confusion matrix was used to evaluate how effective the models performed. The best five predictors from 26 features were myocardial infarction, SpO2, neutrophil, D dimer, and creatinine. The results indicate that the random forest algorithm showed better performance than other ML algorithms in terms of accuracy, sensitivity, precision, specificity, and area under the curve (AUC), achieving values of 84.15%, 84.0%, 84.1%, 83.9%, and 90.02%, respectively. Implementing ML techniques can accurately predict the mortality rate associated with COVID-19. Therefore, this predictive model can help clinicians and hospitals predict COVID patients with a greater risk of death and effectively target more appropriate treatments.

IMPLEMENTATION OF MONITORING SIDE EFFECTS OF DRUGS IN DRUG-RESISTANT TUBERCULOSIS PATIENTS IN REFERRAL HOSPITALS: A QUALITATIVE STUDY Elmiawati Latifah; Endang Yuniarti; Rinto Susilo; Hidayah Karuniawati; Azizah, Nur; Dyah Aryani Perwitasari; Syifa Imelda
Medical Sains : Jurnal Ilmiah Kefarmasian Vol 9 No 4 (2024)
Publisher : Sekolah Tinggi Farmasi Muhammadiyah Cirebon

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37874/ms.v9i4.1294

Drug-resistant tuberculosis (TB) is a public health problem that poses major challenges to patients, health workers, society, and the health care system. This research is a qualitative study to explore the implementation of drug side-effect monitoring and the role of health workers in handling side-effect monitoring medication for tuberculosis patients. We collected data through Focus Group Discussions (FGD) and conducted direct, in-depth interviews. The informants in this study were doctors, pharmacists, and nurses who were directly involved in treating drug-resistant tuberculosis patients. Two drug-resistant TB referral hospitals in the Cirebon area hosted the research. INVIVO 12 was used for qualitative analysis. Both hospitals still need to optimise the mechanism for tracking drug side effects in drug-resistant TB patients in accordance with the technical guidelines. Doctors at both hospitals play a significant role in implementation compared to other health workers. The similar role of doctors in both hospitals in implementation is in initial examination and history taking, determining causality, management, and education regarding drug side effects. Pharmacists have a similar role in managing drug side effects and documenting "unwanted events". The role of nurses in both hospitals is similar, namely providing patients with education on drug side effects. Efforts are needed to increase the implementation of monitoring of drug side effects by conducting assessments of the causality of drug side effects and documentation using specific instruments according to standards, ensuring the ensuring the completeness of manual monitoring forms, and providing continuous drug side effect monitoring training for health workers.

Co-Authors Abdi Wira Septama Adi Wira Septama Adnan Adnan Adnan Adnan Adnan Adnan Adnan, Adnan Adriyanto Rochmad Basuki Agung Permata Ahmad Azrul Zuniarto Aisyi, Mururul Ajeng Diantini Ajeng Diantini Akrom, Akrom Ambarwati, Sindy Cisna Anak Agung Gede Sugianthara Ananda Muhammad Naafi Ananda Muhammad Naafi, Ananda Muhammad Andalusia, Rizka Andriana Sari Andriana Sari Andriana Sari Andriana Sari Angella, Widi Anisa Nova Puspitaningrum Anisa Nova Puspitaningrum Annisa Annisa Awalia Rahma MH Sibadu Ardan Kensanovanto Arief Muttaqien Arief Rahman Afief Arifin, Bustanul Ariska Wigatiningtyas Astagiri Yusuf, Prasandhya Athika Darumas Putri Aulia Rahman B Simanjuntak, Lamhot Baiq Adelina Atbam Munawwarah Baiq Nurbaety Bambang Purwoko Barkah Djaka Purwanto Barkah Djaka Purwanto Baroroh, Faridah Bayu Prio Septiantoro Bayu Prio Septiantoro Bayu Prio Septiantoro Bayu Tri Murti Berry H Putra Boisi, Cici Feronika Bramadi Arya Bustanuddin As Suaidy Bustanul Arifin Bustanul Arifin Candradewi, Susan Fitria Cheung, Rocky Cut Fatia Ulfa Cut Fatia Ulfa Damayanti, Elok Dania Haafizah Darwis Darwis darwis darwis, darwis Denys Chichi Kusumastuti Desi Kusumawati, Desi Desty Kusumaningsih Dewi Wulandari Dewi Wulandari Dewi, Masita Sari Dian Prasasti Dian Prasasti Dias Ananda Sulistya Didi Rohadi Didik Setiawan Didik Setiawan Dwi Utami Eka Wuri Handayani Elli Nur Hayati Endang Darmawan Endang Darmawan Endang Darmawan Endang Yuniarti Endang Yuniarti Endang Yuniarti Esty Elvinda Farah Bidara Farida, Imaniar Noor Faridah Baroroh Faridah, Imaniar Fatimah Sri Kurniawati Fatimah, Salma Auliya Fatkhiya, Musa Fitri Febriana, Sri Awalia Febriana, Sri Awalia Fitri Nur Mahmudah Fredrick Dermawan Purba Gina Noor Djalilah Gugun Suhendra Gugun Suhendra Gurning, Sri Handayani Haafizah Dania Haafizah Dania Haafizah Dania Haafizah Dania Haafizah Dania Haafizah Dania Hadiq, Shabran Handayani, Eka Wuri Haridini Intan Mahdi Haridini Intan Mahdi Haridini Intan Mahdi Hasniah Hasniah Hazena Misgi Damayanti, Hazena Misgi Hendrik Hendrik Hendy Ristiono, Hendy Herjanti Ratnawiningsih Herjanti Ratnawiningsih Herjuna Hardiyanto Herlina, Tetie Hidayah Karuniawati Ikrimah Nisa Utami Imaniar Faridah Imaniar Noor Faridah Imaniar Noor Faridah Imaniar Noor Faridah Imaniar Noor Faridah Imaniar Noor Faridah Imaniar Noor Faridah Imaniar Noor Faridah Imaniar Noor Faridah Intan Fatah Kumara Irma Risdiana Irma Risdiana Irma Risdiana, Irma Iskak, Iskak Islami, Safira Nur Jamhari Jamhari Jarir At Thobari Juwita, Dina Ratna Kania Agustina Kaptein, A.A Khuluq, Husnul Kiki Lukman Kintoko, Kintoko Kodriati, Nurul Kuluq, Muhammad Husnul Kurniawan, Nurcholid Umam Kurniawati, Fatimah Sri Kurniyati, . Kurniyati, . Lalu M Irham Lalu Muhammad Irham Lamhot B Simanjuntak Lamhot B Simanjuntak Lamhot B Simanjuntak Lestari, Mardiana Puji Lianawati Lianawati Like Efriani Lisza Niarisessa Lutfi Sukma Pratiwi Luthfiah Luthfiah M Rifqi Rokhman M. Rifqi Rokhman M. Rifqi Rokhman M. Rifqi Rokhman Made Ary Sarasmita Mahdi, Haridini Intan Mahfudh , Nurkhasanah Maliza, Rita Marwin Marwin Marwin Marwin Masita Sari Dewi Meki Pranata Melinda Widianingrum Melinda Widianingrum Melodia Rezadhini Melodia Rezadhini Menit Ardhiani Menit Ardhiani Muamala, Anisa Muh. Deni Kurniawan Muhammad AR Saputra Muhammad Ardhani Muhammad Dwi Suprobo Muhammad Fathurrahman Muhammad Thesa Ghozali Mukti A Berlian Muliyani Muliyani Muliyani Muliyani Muliyani, Muliyani muliyani, muliyani muliyani Mulyani, Sri Mumfasiroh Saputri Mururul Aisyi Mururul Aisyi mustika muthaharah Mustika Muthaharah Mustofa Mustofa muthaharah, mustika Mutmainnah Siradjuddin Muttaqien, Arief Nabial Chiekal Gibran Nabilah Nabilah Nabilah Nabilah Nadia Utami Noor Naili Ra fi'ah Nanik Sulistyani Nasriyah, Chotijatun Nazhipah Isnani Nguyen, Thang Ni Made Ary Sarasmita Nidia Yuni Lestari Nidia Yuni Lestari, Nidia Ninda Sari Wahyuningtyas Noerhidayati, Elly Novi Milasari Novitasari, Putri Rachma Nuni Ihsana Nur Aida Nur Azizah Nur Mahdi Nur Rahmi Hidayati, Nur Rahmi Nurcholid Umam Nurcholid Umam Kurniawan Nurcholid Umam Kurniawan Nurcholid Umam, Nurcholid Nurfadilasari, Ulfa Mustofa Nurkhasanah Mahfudh Nurul Kodriati Nyoman Kertia Oni Yulianta Wilisa P.D. Pratiwi Pandanwangi , Siti Pendicho Eko Yuliyanto Permatasari, Anggraeni Pradika, Jaka Pradipta, Indra Prasasti, Dian Pratama, Kharisma Pratiwi, P.D. Purwanto, Barkah Djaka Puspitaningrum, Anisa Nova Putri Pertiwi Qarriy 'Aina Urfiyya Qarriy Aina Urfiyya Ra fi'ah, Naili Ra fi'ah, Naili Rachma Greta Putri Ratu Matahari Ratu Matahari Retno Murwanti Reza Aditya Nugroho Rezadhini, Melodia Riana Prastiwi Handayani Rini, Vina Angga Rizka Andalusia Rizka Andalusia Rizka Andalusia Rizka Novia Atmadani Rizky, Muhammad Arif Robi’ah Adawiyah Rocky Cheung Rocky Cheung Rocky Cheung RR. Ella Evrita Hestiandari Rr. Erni Kusuma Putri Sabaan, Wahid Sabaan, Wahid Saidah Rauf Santoso, Setiyo Budi Satibi Satibi Sawitri Sawitri Sawitri Sawitri Septiantoro, Bayu Prio Setiyati Jatiningsih Simanjuntak, LB Sindy Cisna Ambarwati Siswandi Siswandi Siswandi Siswandi Siswandi Siswandi Siswandi, Siswandi Siti Pandanwangi Siti Urbayatun Solikhah Sri Awalia Febriana Sri Handayani Gurning Sri Mulyani Suhendra, Gugun Suin Rina Dewi Sulastri Sulastri Sulastri Sulastri Supadmi, Woro Woro Supadmi Susan Fitri Candradewi Susan Fitri Candradewi Susan Fitria Candradewi Susilo, Rinto Suwijiyo Pramono Syifa Imelda Teguh Uji Sungkowo Tomi . Triantoro Safaria Triantoro Safaria Tuty Lia Syahfitri Ully Adhie Mulyani Ully Adhie Mulyani Vicryanto Halid Vina Angga Rini Wahyu Rahmatulloh Wahyu Widyaningsih Wahyudi, Andrey Wilisa, Oni Yulianta Wilisa, Oni Yulianta Wirawan Adikusuma Woro Supadmi Woro Supadmi Woro Supadmi Woro Supadmi Woro Supadmi Wulandari, D Yeni Alfiana Ratnasari Yudha Rizky Nuari Yuli Rachmawati Yuli Rachmawati Yusuf, Prasandhya Astagiri Zulkarnain Zulkarnain Zulkarnain Zulkarnain Zuniarto, Ahmad Azrul

Title

Found 174 Documents
Search

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Title Search

Found 174 Documents Search

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Title

Found 174 Documents
Search